(1 - 11 von 18
)
Novartis International AG | Eucreas�, a single-tablet combination of...
www.investegate.co.uk
[5] American Diabetes Association. Standards of Medical Care in Diabetes http://care.diabetesjournals.org/cgi/content/full/29/suppl_1/s4 [6] International Diabetes Federation Diabetes Atlas. Third edition 2006: http://www.eatlas.idf.org/ # # # Novartis Media Relations John Gilardi Navjot Rai Novartis ...
GeneFormatics and Incyte Genomics Sign Collaborative Agreement to...
investor.incyte.com
CONTACT: Mentus (for GeneFormatics) Linda Seaton/Navjot Rai, ext.133/ext or Incyte ...
Neue Kooperationen und bahnbrechende Fortschritte in der...
www.finanznachrichten.de
Medienkontakt: Navjot Rai Santaris Pharma A/S, USA Büro: + ext Mobil: +
Media Releases - Novartis
cws.huginonline.com
John Gilardi. Novartis Global Media Relations. + (direct). + (mobile). . Navjot Rai.
Neurocrine Biosciences to Present at the Jefferies London...
tradeshownews.vporoom.com
For further information: Neurocrine Biosciences, Inc., Navjot Rai (Media & Investors). For more trade show ...
New collaborations and breakthrough advancements in RNA-based drug...
gildehealthcare.com
Denmark-based Santaris Pharma A/S appoints leading RNA industry expert Art Levin Ph.D. as President of US operations and Chief Development Officer
Santaris Pharma A/S Advances Miravirsen, The First MicroRNA-Targeted...
www.science20.com
CONTACT: Navjot Rai, Director, Global Communications of Santaris Pharma,A/S, Office, + , ext. 206, Cell, +
Visit Profile - Events.com
secure.eventsonline.ca
Pledge Profile Page of: Navjot Rai. Spread the word! Use the social media links below to let your friends/family know. Donation Info: Total Donations: $
New data show breakthrough microRNA-targeted | EurekAlert!
www.eurekalert.org
A study published online in this week's Science shows that SPC3649, a breakthrough microRNA-targeted therapy developed by Santaris Pharma A/S using its...
New Data Shows Breakthrough MicroRNA-Targeted Therapy Developed Using...
www.science20.com
SOURCE: Santaris Pharma A/S. CONTACT: Navjot Rai, Santaris Pharma A/S, Office: + ext.206, Cell: + ,
sortiert nach Relevanz / Datum